Please assess the completion status of the following clinical trial:

Trial Title: A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Measurable disease with diagnosis of Small Cell Lung Cancer.~* Performance status of 0 to 1 on the Eastern Cooperative Oncology Group performance status schedule.~* Patients must be at least 18 years of age and have at least a 12-week life expectancy.~* No prior chemotherapy and/or prior thoracic radiotherapy.~* Adequate pulmonary function and organ function.~Exclusion Criteria:~* Patients with myocardial infarction within the preceding six months.~* Diagnosis of a serious concomitant systemic disorder.~* Prior radiotherapy to the lower neck or abdominal region.~* Significant weight loss.~* Concurrent administration of any other antitumor therapy.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).